17-beta-hydroxysteroid dehydrogenase deficiency medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{17-beta-hydroxysteroid dehydrogenase deficiency}} | {{17-beta-hydroxysteroid dehydrogenase deficiency}} | ||
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]]. Feminizing [[genitoplasty]] and [[gonadectomy]] must be performed, if female assignment is opted. <ref name="urlOrphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency">{{cite web |url=https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=752&lng=EN |title=Orphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency |format= |work= |accessdate=}}</ref> | {{CMG}}; {{AE}} {{Abdulkerim}} | ||
==Overview== | |||
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]]. | |||
==Medical therapy== | |||
*If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, [[gender]] assignment should be discused, depending on the expected result of [[verilizating]] [[genitoplasty]]. | |||
*Feminizing [[genitoplasty]] and [[gonadectomy]] must be performed, if female assignment is opted. <ref name="urlOrphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency">{{cite web |url=https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=752&lng=EN |title=Orphanet: 46,XY disorder of sex development due to 17 beta hydroxysteroid dehydrogenase 3 deficiency |format= |work= |accessdate=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 09:31, 23 May 2022
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency medical therapy On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy |
|
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy |
|
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy |
|
17-beta-hydroxysteroid dehydrogenase deficiency medical therapy in the news |
|
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Overview
If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discused, depending on the expected result of verilizating genitoplasty.
Medical therapy
- If the diagnosis of 17 beta hydroxysteroid dehydrogenase deficiency is made at birth, gender assignment should be discused, depending on the expected result of verilizating genitoplasty.
- Feminizing genitoplasty and gonadectomy must be performed, if female assignment is opted. [1]